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A 46-year-old woman with MELAS syndrome (myopathy,
encephalopathy, lactic acidosis, and stroke-like episodes)
attended our chronic renal failure clinic. She had a previous
stroke, sensorineural deafness, hypertrophic cardiomyopathy,
and type 2 diabetes. A renal biopsy demonstrated focal and
segmental glomerulosclerosis.
The patient also had 4 years of worsening night vision
and reduced visual acuity. Fundoscopy revealed bilateral
depigmented areas consistent with pigment epithelium
atrophy (Figure 1) that were confirmed with optical
coherence tomography (OCT) (Figure 2).
MELAS syndrome affects one in 10 000 individuals and
is due to an A3243G mutation in mitochondrial DNA.
Obvious retinal atrophy occurs in at least 50% patients but
90% have abnormal electroretinography. Focal and segmental
glomerulosclerosis presents as steroid-resistant nephrotic
syndrome that advances to renal failure by middle age.
MELAS syndrome resembles Alport syndrome, in that
both are familial and result in renal failure and hearing loss.
However, MELAS patients have proteinuria, glomerulo-
sclerosis, diabetes, and retinal atrophy, whereas Alport
syndrome patients have hematuria, a lamellated glomerular
basement membrane, and dot-and-fleck retinopathy.
Retinal atrophy and focal and segmental glomerulo-
sclerosis (FSGS) may occur in MELAS syndrome through
the same mechanism, since the inner retinal layers structu-
rally resemble the glomerular filtration barrier. Further-
more, this association with retinal atrophy may aid our
understanding of the pathogenesis of FSGS.
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Figure 1 | Retinal atrophy associated with focal segmental
glomerulosclerosis in MELAS syndrome. (a) Examination of the
left eye showed extensive retinal pigment epithelial thinning at
the posterior pole, with retinal arteriolar attenuation. The disk
was normal and there were no features of diabetic retinopathy.
(b) Normal eye.
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Figure 2 | Optical coherence tomography demonstrated bilateral
and generalised retinal thinning (green – thinned; yellow – very
thinned; red – extremely thinned; in right eye (on left) and left
eye (on right)).
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